Christopher Lewis Stone - Net Worth and Insider Trading
Christopher Lewis Stone Net Worth
The estimated net worth of Christopher Lewis Stone is at least $1 Million dollars as of 2024-12-27. Christopher Lewis Stone is the VP, Gen. Counsel & Secretary of PDL BioPharma Inc and owns about 405,559 shares of PDL BioPharma Inc (PDLI) stock worth over $1 Million. Details can be seen in Christopher Lewis Stone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Lewis Stone has not made any transactions after 2020-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Lewis Stone
Christopher Lewis Stone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Lewis Stone owns 1 companies in total, including PDL BioPharma Inc (PDLI) .
Click here to see the complete history of Christopher Lewis Stone’s form 4 insider trades.
Insider Ownership Summary of Christopher Lewis Stone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDLI | PDL BioPharma Inc | 2020-12-16 | VP & Gen. Counsel & Secretary |
Christopher Lewis Stone Latest Holdings Summary
Christopher Lewis Stone currently owns a total of 1 stock. Christopher Lewis Stone owns 405,559 shares of PDL BioPharma Inc (PDLI) as of December 16, 2020, with a value of $1 Million.
Latest Holdings of Christopher Lewis Stone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PDLI | PDL BioPharma Inc | 2020-12-16 | 405,559 | 2.47 | 1,001,731 |
Holding Weightings of Christopher Lewis Stone
Christopher Lewis Stone Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Lewis Stone has made a total of 1 transactions in PDL BioPharma Inc (PDLI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in PDL BioPharma Inc is the sale of 200,000 shares on December 16, 2020, which brought Christopher Lewis Stone around $512,000.
Insider Trading History of Christopher Lewis Stone
- 1
Christopher Lewis Stone Trading Performance
Christopher Lewis Stone Ownership Network
Christopher Lewis Stone Owned Company Details
What does PDL BioPharma Inc do?
Who are the key executives at PDL BioPharma Inc?
Christopher Lewis Stone is the VP & Gen. Counsel & Secretary of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP Finance & CAO and Acting CFO Edward Imbrogno , and VP & Business Development Jill M. Jene .
PDL BioPharma Inc (PDLI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDL BioPharma Inc Insider Transactions
Christopher Lewis Stone Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Lewis Stone. You might contact Christopher Lewis Stone via mailing address: 932 Southwood Blvd. Incline Village Nv 89451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
